PUBLISHER: iData Research Inc. | PRODUCT CODE: 1847180
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1847180
Please contact us using the inquiry form for pricing information.
The U.S. anesthesia, respiratory and sleep management device market was valued at nearly $7 billion in 2024. The market is projected to grow to approach $9 billion over the forecast period.
This report covers anesthesia delivery units, anesthesia monitors, anesthesia information management systems, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices, sleep diagnostic devices, and extracorporeal membrane oxygenation (ECMO) systems.
Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.
Qualitative coverage includes market drivers and limiters, mergers and acquisitions, product portfolios, recalls where relevant, and competitive positioning across hospitals, ambulatory surgery centers, and home care.
Market Overview
Demographic shifts and technology adoption continue to shape U.S. demand for ARS devices. An aging population and rising obesity rates increase the burden of respiratory disease and sleep apnea while also lifting surgical volumes that depend on safe anesthesia care.
Health systems have modernized anesthesia delivery and monitoring fleets to work with electronic medical record systems, which changed replacement timing and procurement priorities. In respiratory and sleep therapy, many devices are moving from stationary to portable formats to support comfort, adherence, and care outside the hospital.
Vendors that combine reliable hardware with simple workflows, data connectivity, and service programs are well positioned as providers standardize across sites of care.
Market Drivers
Demographic pressure. Baby boomers represent the largest share of the U.S. population. Obesity affects an estimated 40 percent of Americans. Both trends raise the need for anesthesia during surgery and increase the number of patients who require respiratory support and sleep apnea therapy.
Shift to home and outpatient care. Portable oxygen concentrators, home ventilators, compact nebulizers, and positive airway pressure devices extend therapy into the home. Ambulatory surgical centers adopt anesthesia monitoring and information systems that fit short stay workflows.
Advancing technology. Modern anesthesia delivery units and ventilators use electronic controls for precision and ease of use. Sleep therapy and diagnostic devices add features that improve comfort and adherence. Mobile apps and remote monitoring support coaching, data sharing, and follow up.
EMR integration and automation. Hospital programs favor devices that support auto programming and auto documentation. This reinforces replacement of older anesthesia delivery units and monitors with systems that can connect to scheduling and record keeping.
Public awareness and testing. Sleep apnea awareness is rising, yet many severe cases remain undiagnosed. Policies that favor home sleep testing increase access to diagnostics and feed more patients into therapy.
Market Limiters
High capital and maintenance costs. Anesthesia delivery units, ventilators, and information systems require upfront investment and ongoing training and service. Budget limits in small hospitals and some public facilities can delay replacement.
Patient non-adherence. Long term therapy for sleep apnea and oxygen requires consistent use. Discomfort or inconvenience reduces adherence, which lowers realized demand compared with the clinical need.
GPO pricing and competitive bidding. Group purchasing organizations compress price corridors. Durable medical equipment bidding programs apply to sleep and oxygen therapy and drive reimbursement reductions, which influence device prices and provider behavior.
Reimbursement pressure. Lower payments for home oxygen and related services reduce provider margins. Policy changes have reduced the number of oxygen suppliers in some regions.
Skilled personnel shortages. Shortages of respiratory therapists, anesthesia professionals, and sleep technologists limit the pace at which services can expand, especially outside major metro areas.
Market Coverage and Data Scope
Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage. Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that affect demand.
Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.
Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.
Method note. Revenue modeling uses units multiplied by ASP, validated against installed base, utilization, and policy impacts for hospital and home settings.
Markets Covered and Segmentation
Anesthesia Delivery Unit (ADU) Market
By setting. Hospital operating room, other hospital suite, ambulatory surgery center.
Anesthesia Monitor Market
By setting. Hospital monitor, ambulatory surgery center monitor.
Anesthesia Information Management System (AIMS) Market
By setting. Hospital, ambulatory surgery center.
Anesthesia Disposables Market
By device type. Anesthesia circuit, anesthesia mask, endotracheal tube, laryngeal mask.
Ventilator Market
By device type. Acute care, sub-acute care, home care, neonatal, non-invasive, emergency transport.
Nebulizer Market
By device type. Compressor or jet, vibrating.
Respiratory Disposables Market
By device type. Oxygen cannula, oxygen mask, tracheostomy tube, resuscitator, incentive spirometer, heat and moisture exchanger.
Oxygen Therapy Market
By device type. Oxygen concentrator, transfilling device, aluminum medical oxygen cylinder, medical oxygen regulator for home care, oxygen conserver, high flow nasal therapy device.
Therapeutic Obstructive Sleep Apnea Market
By device type. Positive airway pressure devices, sleep therapy interfaces.
Sleep Diagnostic Device Market
By device type. Type I, Type II, Type III, Type IV.
Extracorporeal Membrane Oxygenation (ECMO) Market
By device type. Machine, disposable.
Competitive Analysis
ResMed led the overall ARS market in 2024 on strength in obstructive sleep apnea. The company also participates in sleep diagnostics and holds a modest share in ventilators and respiratory disposables.
Philips ranked second on the basis of anesthesia monitors. It previously led in ventilators, OSA, sleep diagnostics, and oxygen therapy, but recall actions caused an exit from those U.S. segments.
CAIRE is a leading name in oxygen concentrators with portable and transportable lines and a stationary product launch in 2025.
Other competitors participate across anesthesia, ventilation, sleep, oxygen therapy, and disposables. Portfolio fit, service networks, and data integrations are important for long term positions.
Technology and Practice Trends
Portable and user friendly devices. Concentrators and nebulizers have become lighter and simpler. PAP systems and interfaces improve comfort to support adherence.
Digitally connected anesthesia. Modern ADUs and monitors are selected based on ease of integration with EMR workflows.
Preparedness and installed base. COVID-19 raised awareness of surge capacity and infection control. While capital markets reset after the initial spike, disposables use remains above pre-pandemic levels in many programs.
Home sleep testing. Policy support for home tests expands access and brings more patients into treatment.
Care Settings
Coverage spans hospitals, ambulatory surgery centers, physician offices where relevant, and home care. Shifts in site of care affect pricing, product selection, logistics, and service models. Vendors address these differences with tailored kits, remote monitoring options, and simple patient interfaces.
Geography
This edition covers the United States.
Where is the largest and fastest growing opportunity within the U.S. anesthesia, respiratory and sleep management device market and which categories contribute most to value creation through 2031.
How does the ARS device market relate to the broader U.S. economy and to provider operations, including staffing, reimbursement, and digital transformation of clinical workflows.
What forces will shape the market going forward, including aging, obesity, outpatient migration, EMR integration, home sleep testing, and preparedness planning.
How will policy and reimbursement affect price and access, including the impact of group purchasing organizations, durable medical equipment bidding programs, and payment changes for home oxygen and sleep therapy.
Which technologies have the clearest adoption path in hospitals and at home, including electronically controlled ventilators and anesthesia delivery units, high flow nasal therapy, PAP devices, and sleep interfaces that improve comfort and adherence.
How should providers and suppliers plan for the rising role of home and ambulatory settings, including training, service coverage, device portability, and data sharing with clinicians and caregivers.
What is the outlook for sleep diagnostics, given the shift to home sleep testing and the need to triage patients efficiently for PAP therapy and follow up.
Which risks could slow market growth, including reimbursement reductions, workforce shortages, adherence barriers, and the financial condition of regional providers.
The U.S. ARS device market report from iData Research answers these questions with segment and setting models, company share analysis, and pricing detail.
Use it to size demand by product and care setting, plan product roadmaps, align service programs with provider constraints, and set targets for pricing, contracting, and inventory.
Please contact us using the inquiry form for pricing information.